Cell Genesys, Inc. (CEGE) – Ceregene Inc. Secures $5.4 Million in Funding for Phase II Studies
Ceregene Inc. concentrates on the delivery of nervous system growth factors to treat neurodegenerative disorders using gene delivery. Specifically, the…
Ceregene Inc. concentrates on the delivery of nervous system growth factors to treat neurodegenerative disorders using gene delivery. Specifically, the…
With headquarters in London, England, PlayBOX (US) Inc. is a global-media entertainment distribution company. They offer a broad range of…
There are innumerable instances in which unfortunate medical circumstances create a need for neurological and muscular rehabilitation therapies. Answering the…
Oil prices spiked more than ten percent on Tuesday, as word of substantially reduced Saudi oil exports reached investors' ears.…
The U.S. dollar fell dramatically against other world currencies on Tuesday, boosting gold and other precious metals, which have been…
The end of the 2008 presidential campaign brought some relief to investors this Tuesday, as the Dow Jones Industrial average…
Elray Resources, Inc. (ELRY.OB) is a junior exploration and development corporation with an established portfolio of highly prospective, heavily mineralized…
Juhl Wind Inc. (Juhl) said today that it has purchased Next Generation Power Systems (NGPS) for 133,213 shares of Juhl…
Microvision, Inc., a global leader in miniature image display and capture systems for mobile devices, announced today that it has…
BioScrip, Inc., the specialty pharmacy and pharmacy services provider, had a double dose of good news today with the announcement…